The Medicaid Drug Rebate Program and the 340B Drug Pricing Program are generally understood as separate efforts to promote drug affordability—one by directly subsidizing low-income patients through ...
State Medicaid programs cover nearly all Food and Drug Administration–approved prescription drugs in exchange for mandatory manufacturer rebates, including rebates that offset price increases beyond ...
In light of concerns over the misclassification of Mylan’s EpiPen and subsequent overcharging of the federal government for the life-saving allergy drug, the Department of Health and Human Services’ ...
April 29 (Reuters) - The U.S. Centers for Medicare & Medicaid Services said on Wednesday it has extended key application deadlines for drugmakers and states to join the payment model, which aims ...
The Centers for Medicare and Medicaid Services (CMS) said Wednesday that state Medicaid programs must cover pharmaceuticals approved under FDA’s accelerated approval (AA) pathway. “In summary, this ...
Prescription drug prices were under the spotlight again this week as Congress held three hearings on lowering costs and Republican Senator Mike Braun introduced a bill to add commercial plans to a ...
The Center for Medicare and Medicaid Innovation (CMMI)[1] recently released information about three new models aimed at testing alternative calculations for manufacturer rebates, to ensure net drug ...
Court blocks Trump administration's drug rebate program for safety-net hospitals Judges cite lack of impact consideration on hospitals Inflation Reduction Act allows Medicare drug price negotiations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results